secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2024-09-30T23:59:59+00:00
Accession:  0001104659-24-103813
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics closes $2.5M public offering of shares and warrants
---------------------------------------------------------------------

- Aggregate gross proceeds of approximately $2.5 million from offering of common shares and warrants.
- Pricing at $1.75 per share and accompanying warrant; warrants exercisable at $2.00 per share for five years.
- Post-offering outstanding shares: 2,272,462; proceeds for working capital, R&D, and manufacturing scale-up.
- A.G.P./Alliance Global Partners served as placement agent with 7% fee plus expense reimbursement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465924103813/0001104659-24-103813-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465924103813/tm2425109d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-103813

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer